Table 4.
Increases in survival by use of FDG-PET on completion of therapy for Hodgkin lymphoma (from Bradbury et al.[19])
Scenario | Increase in survival compared with surveillance for all patients (years) | Increase in survival compared with consolidation for all patients (years) |
---|---|---|
Female 20 years | 1.2 | 0.7 |
Female 40 years | 1.6 | 0.6 |
Female 40 years | 0.7 | 1.6 |
Male 20 years | 1.5 | 0.6 |
Male 40 years | 1.3 | 0.9 |
Male 60 years | 0.4 | 2.0 |